Class II · ModerateActive recall
Cimzia
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot: CVZFW, Exp.:2026-JUL-04; CVZYG, Exp.: 2026-AUG-19; CWSYT, Exp.: 2026-OCT-22; CWDZY, Exp.:2026-NOV-20; CWTSD, Exp.:2026-DEC-11; CVTFK, Exp.:2026-JUL-04; CVTSN, Exp.: 2026-AUG-19; CWVGP. Exp.:2026-DEC-11; CVWXT, CVWXV, CVWXW, Exp.:2026-JUL-04; CWHFF, Exp.: 2026-OCT-22; CWNDS, Exp.: 2026-DEC-11.
Where it was soldUS Nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of Assurance of Sterility
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byUCB Inc., Smyrna, GA 30080, a)
| Brand name | CIMZIA |
| Generic name | CERTOLIZUMAB PEGOL |
| Distributed by / for | UCB Biosciences Inc. |
| NDC | 50474-710-79 |
Show the full FDA record
| Full product label | cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, NDC 50474-710-81. |
| Recalling firm | UCB Biosciences Inc. |
| Distribution | US Nationwide. |
| Quantity | 141,708 cartons |
| Recall initiated | 2026-05-08 |
| Report date | 2026-05-27 |
| Recall completed | — |
| Recall number | D-0546-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Smyrna GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.